// App-Quantinova.ai

453 2016 BCVS : The G Protein-coupled Estrogen Receptor GPER/GPR30 is a Potential Therapeutic Target for Cardiovascular Inflammation

Researchers

Presenter

  • Victor Nizet

Principal Investigators

  • Paul A Insel

  • Ross Corriden

Medical Centers

  • University of California-San Diego, San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

  • Cyclic adenosine monophosphate

Drug/Treatment

  • Phorbol myristate acetate

  • Raloxifene

  • Immunol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved